Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_assertion description "[Strikingly, the expression level of Notch-1 pathway components was critical, because exosomal nanoparticles decreased the proliferation of cells in which these partners are either weakly represented, in differentiated adenocarcinoma cells, or inhibited, in poorly differentiated carcinoma cells, by blocking presenilin in the gamma-secretase complex that regulates the Notch-1 pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_assertion evidence source_evidence_literature NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_assertion SIO_000772 19405120 NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_assertion wasDerivedFrom befree-20150227 NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_assertion wasGeneratedBy ECO_0000203 NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP595058.RAohD_F9MtFPwwllDyzSikp4Ccr3wT1oKUR1eLjTaXNMk130_provenance.